Significant benefits are seen with motavizumab, nirsevimab, and palivizumab for prevention of respiratory syncytial virus (RSV) in infants and children, according to a review published online Feb. 17 in JAMA Network Open.
Mar 7, 2023
0
37
For many parents, respiratory syncytial virus—or RSV—which has been causing record numbers of hospitalizations of children during the fall of 2022, may sound like a relatively new and unheard-of threat. But in fact, RSV is ...
Dec 16, 2022
0
21
What is RSV?
Nov 28, 2022
0
34
What does the rise in RSV, or respiratory syncytial virus, mean for your children? We asked Colleen Nash, MD, MPH, a pediatric infectious diseases specialist at RUSH, to offer some guidance on keeping your family safe this ...
Oct 31, 2022
0
38
While a potential COVID winter surge and the impending flu season get a lot of attention, doctors are worried about another virus.
Oct 28, 2022
0
35
Respiratory syncytial virus, more commonly known as RSV, sends thousands of children to the hospital every year in the U.S. But during September and October 2022, health professionals across the country have watched an unprecedented ...
Oct 27, 2022
0
32
Some California children's hospitals are straining under a surge of RSV, a respiratory illness that can cause babies to struggle to breathe.
Oct 26, 2022
0
42
Pediatricians' offices, children's hospitals, urgent care centers and emergency rooms across the United States are being overwhelmed by an early, heavy surge of respiratory syncytial virus (RSV) among infants and young children.
Oct 25, 2022
0
151
Children's hospitals in parts of the U.S. are seeing a surge in a common respiratory illness that can cause severe breathing problems for babies.
Oct 25, 2022
0
39
Respiratory syncytial virus (RSV), a virus that can cause severe problems, especially for young children and older adults, has increased illness and hospitalizations.
Oct 14, 2022
0
39
